XENE Nasdaq 2020 - 03 - 09

Xenon Pharmaceuticals Inc.

XENE | $40.36 -3.05% -3.15% 320K

(0.0% 1d) (-6.1% 1m) (9.6% 1y) (0.0% 2d) (0.3% 3d) (0.8% 7d) (-3.76% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 3,044,454,974
http://www.xenon-pharma.com
Sec Filling | Patents | 104 employees

(CA) Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

nervous system neurological

add to watch list Paper trade email alert is off

Press-releases

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-16 (Crawled : 13:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K

Health Technology

| 0.77% | O: 0.0% H: 1.73% C: 0.44%
xen1101 neurology pharmaceuticals meeting

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K

Health Technology

| -3.25% | O: -1.05% H: 1.69% C: -0.35%
conference pharmaceuticals

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 20:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K

Health Technology

| -1.37% | O: -0.4% H: 1.57% C: 0.5%
conference pharmaceuticals

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
Published: 2024-03-12 (Crawled : 20:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K

Health Technology

| -5.92% | O: 0.34% H: 1.7% C: 1.53%
pharmaceuticals

Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K

Health Technology

| -9.5% | O: 0.0% H: 3.13% C: -0.09%
conference biopharma pharmaceuticals global

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 21:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K

Health Technology

| -11.8% | O: 5.3% H: 2.6% C: -5.75%
year update pharmaceuticals financial results

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
Published: 2024-02-22 (Crawled : 21:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K

Health Technology

| -15.47% | O: -0.08% H: 0.61% C: 0.51%
conference year update pharmaceuticals financial results

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K

Health Technology

| -8.51% | O: -0.53% H: 6.05% C: 5.79%
pharmaceuticals key milestone

Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 14:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K

Health Technology

| -7.3% | O: -0.47% H: 0.47% C: -1.14%
conference pharmaceuticals

Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2023-12-04 (Crawled : 21:00) - globenewswire.com
XENE | $40.36 -3.05% -3.15% 320K

Health Technology

| 10.25% | O: 0.4% H: 2.35% C: 2.19%
offering pharmaceuticals

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0000950170-24-030250	4	2024-03-12	2024-03-11	Buy	A	100000	100000
0000950170-24-030245	4	2024-03-12	2024-03-11	Buy	A	100000	100000
0000950170-24-030239	4	2024-03-12	2024-03-11	Buy	A	100000	100000
0000950170-24-030236	4	2024-03-12	2024-03-11	Buy	A	65000	65000
0000950170-24-030233	4	2024-03-12	2024-03-11	Buy	A	65000	65000